Methodological Recommendations for the Diagnostics of EGFR Gene Mutations and ALK Gene Rearrangement in the Selection of Non-Small-Cell Lung Cancer Patients to Molecularly Targeted Therapies
Abstract
Share and Cite
Krawczyk, P.; Chorostowska-Wynimko, J.; Dziadziuszko, R.; Jassem, J.; Krzakowski, M.; Langfort, R.; Puacz, E.; Wasąg, B.; Wojas-Krawczyk, K. Methodological Recommendations for the Diagnostics of EGFR Gene Mutations and ALK Gene Rearrangement in the Selection of Non-Small-Cell Lung Cancer Patients to Molecularly Targeted Therapies. Adv. Respir. Med. 2014, 82, 437-444. https://doi.org/10.5603/PiAP.2014.0057
Krawczyk P, Chorostowska-Wynimko J, Dziadziuszko R, Jassem J, Krzakowski M, Langfort R, Puacz E, Wasąg B, Wojas-Krawczyk K. Methodological Recommendations for the Diagnostics of EGFR Gene Mutations and ALK Gene Rearrangement in the Selection of Non-Small-Cell Lung Cancer Patients to Molecularly Targeted Therapies. Advances in Respiratory Medicine. 2014; 82(5):437-444. https://doi.org/10.5603/PiAP.2014.0057
Chicago/Turabian StyleKrawczyk, Paweł, Joanna Chorostowska-Wynimko, Rafał Dziadziuszko, Jacek Jassem, Maciej Krzakowski, Renata Langfort, Elżbieta Puacz, Bartosz Wasąg, and Kamila Wojas-Krawczyk. 2014. "Methodological Recommendations for the Diagnostics of EGFR Gene Mutations and ALK Gene Rearrangement in the Selection of Non-Small-Cell Lung Cancer Patients to Molecularly Targeted Therapies" Advances in Respiratory Medicine 82, no. 5: 437-444. https://doi.org/10.5603/PiAP.2014.0057